Researchers have discovered that an ion channel protein called TRPML3 may be a new therapeutic target for chronic obstructive…
Marta Figueiredo, PhD
Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marta Figueiredo, PhD
A single alteration in the sequence of the CHRNA5 gene that leads to inflammation, tissue remodeling, and abnormal repair of…
Dark-field chest X-ray imaging provides greater detail of lung microstructure than standard chest X-rays, and allows for the accurate diagnosis…
Treatment with the antioxidant N-acetylcysteine (NAC) lowered blood levels of pro-inflammatory molecules and reduced lung scarring, or fibrosis, in a…
Repeated lung injury increases the biological age of lung stem cells and progressively diminishes their regenerative abilities, according to a…
Treatment with human mesenchymal stem cells (MSCs) results in a strong, but temporary, reduction in pro-inflammatory molecules involved in…
The Zephyr Endobronchial Valve leads to sustained and significant improvements in lung function, exercise capacity, and quality of life…
Hospitalizations for chronic obstructive pulmonary disease (COPD) dropped by half after the implementation of public health measures to curb…
Treatment with human mesenchymal stem cells (MSCs) effectively lessened hard-to-treat non-tuberculous mycobacteria (NTM) lung infection, and its associated weight loss,…
The U.S. Food and Drug Administration (FDA) has cleared the start of an international pivotal trial to test the…